Surgical Treatment of Trichilemmal Carcinoma

World J Oncol. 2018 Nov;9(5-6):141-144. doi: 10.14740/wjon1143w. Epub 2018 Nov 23.

Abstract

Background: To investigate the clinicopathologic characteristics and prognostic factors of trichilemmal carcinoma (TC), and to determine an optimal treatment strategy for these patients.

Methods: This retrospective study enrolled consecutive patients who were admitted to the Sun Yat-sen University Cancer Center between 1998 and 2012.

Results: The key prognostic factors influencing the survival were lymph nodes metastasis and surgery margin. Multivariate analysis revealed that there was no risk factor for patient survival.

Conclusions: Surgery margin and lymph nodes metastasis were prognostic factors that influenced the treatment outcome. Simple excision with 1 cm margins is safe, inexpensive and effective for the treatment of TC; and postoperative follow-up of the patient to facilitate early diagnosis of the recurrence and distant metastasis is necessary. Systemic chemotherapy should be considered for the distance metastases patients.

Keywords: Chemotherapy; Locoregional recurrence; Lymph nodes metastasis; Treatment strategy; Trichilemmal carcinoma.